000148755 001__ 148755
000148755 005__ 20240229133153.0
000148755 0247_ $$2doi$$a10.1016/j.exger.2019.110815
000148755 0247_ $$2pmid$$apmid:31857132
000148755 0247_ $$2ISSN$$a0531-5565
000148755 0247_ $$2ISSN$$a1873-6815
000148755 0247_ $$2altmetric$$aaltmetric:73100578
000148755 037__ $$aDKFZ-2019-03268
000148755 041__ $$aeng
000148755 082__ $$a610
000148755 1001_ $$aEbert, Helen$$b0
000148755 245__ $$aAssociation between advanced glycation end products, their soluble receptor, and mortality in the general population: Results from the CARLA study.
000148755 260__ $$aAmsterdam [u.a.]$$bElsevier Science$$c2020
000148755 3367_ $$2DRIVER$$aarticle
000148755 3367_ $$2DataCite$$aOutput Types/Journal article
000148755 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1611213077_29169
000148755 3367_ $$2BibTeX$$aARTICLE
000148755 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000148755 3367_ $$00$$2EndNote$$aJournal Article
000148755 500__ $$aVolume 131, March 2020, 110815
000148755 520__ $$aAssociation between advanced glycation end products, their soluble receptor, and mortality in the general population: Results from the CARLA study.
000148755 536__ $$0G:(DE-HGF)POF3-323$$a323 - Metabolic Dysfunction as Risk Factor (POF3-323)$$cPOF3-323$$fPOF III$$x0
000148755 588__ $$aDataset connected to CrossRef, PubMed,
000148755 7001_ $$aLacruz, Maria Elena$$b1
000148755 7001_ $$aKluttig, Alexander$$b2
000148755 7001_ $$aSimm, Andreas$$b3
000148755 7001_ $$0P:(DE-He78)e0ac0d57cdb66d87f2d95ae5f6178c1b$$aGreiser, Karin Halina$$b4$$udkfz
000148755 7001_ $$aTiller, Daniel$$b5
000148755 7001_ $$aKartschmit, Nadja$$b6
000148755 7001_ $$aMikolajczyk, Rafael$$b7
000148755 773__ $$0PERI:(DE-600)2005397-6$$a10.1016/j.exger.2019.110815$$gp. 110815 -$$p110815$$tExperimental gerontology$$v131$$x0531-5565$$y2020
000148755 909CO $$ooai:inrepo02.dkfz.de:148755$$pVDB
000148755 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e0ac0d57cdb66d87f2d95ae5f6178c1b$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000148755 9131_ $$0G:(DE-HGF)POF3-323$$1G:(DE-HGF)POF3-320$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lHerz-Kreislauf-Stoffwechselerkrankungen$$vMetabolic Dysfunction as Risk Factor$$x0
000148755 9141_ $$y2020
000148755 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000148755 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000148755 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000148755 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bEXP GERONTOL : 2017
000148755 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000148755 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000148755 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000148755 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000148755 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000148755 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000148755 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000148755 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000148755 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000148755 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000148755 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000148755 980__ $$ajournal
000148755 980__ $$aVDB
000148755 980__ $$aI:(DE-He78)C020-20160331
000148755 980__ $$aUNRESTRICTED